Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
PALATIN TECHNOLOGIES, Inc. Add to My Watchlist (AMEX: PTN) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     PALATIN 0.27 - (+0.00%) -
4C Cedarbrook Drive
Cranbury, NJ 08512 US
(609) 495-2200
(609) 495-2201 fax
www.palatin.com
CEO Dr. Carl Spana, Ph.D.
Auditor KPMG LLP
Exchange Traded AM
ISIN Number US6960773041
CIK Number 911216
NAICS Code 325412
Business Summary
A biopharmaceutical company, engaged in the development of peptide, peptide mimetic and small molecule agonist compounds with a focus on melanocortin and natriuretic peptide receptor systems.
Number of Employees 43
Share Fundamentals
Market Cap 25.97M
Shares Outstanding 96.17M
Float 92.47M
Short Interest 636.58K
Financial Strength
Revenue (TTM) $14,259,619
Earnings (TTM) -$556,065
Quick Ratio 1.4:1
Current Ratio 1.4:1
Total Debt/Equity 0.01:1
Profitability
Gross Margin N/A
EBITDA Margin -12.3%
Profit Margin -16.1%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs